“…All sixteen studies selected for the review were in-vitro studies published in English. The effects of FWGE were investigated on the following cell lines: - Jurkat leukemic T cells were studied by three studies [ 18 , 21 , 32 ] and the treatment resulted in cytotoxic effects, alteration of the cell cycle, antiproliferative effects, and induction of apoptosis;
- Lymphoma cells were subjected to the treatment and the effects investigated by three studies [ 21 , 27 , 32 ] showed growth inhibition, induction of apoptosis, antiproliferation, and cytotoxic effects;
- Gastric cancer cell line experiments reported in three papers [ 22 , 25 , 26 ] found antiproliferative, cytotoxic, cytostatic, and growth-delay effects;
- Ovarian cancer cell lines, when subjected to treatment with AVEMAR, showed cytotoxic effects [ 23 ], antiproliferative activity [ 25 ], and suppression of cell proliferation [ 29 ];
- Breast cancer cell lines appeared to undergo cytotoxicity and apoptosis [ 24 , 25 , 26 , 32 ], while, in one study [ 33 ] investigating the combined administration of AVEMAR and cytostatics, the treatment with AVEMAR resulted in no increase or decrease of cell viability compared to untreated cells;
- When applied to colon cancer cell lines, FWGE showed antiproliferative activity [ 25 ], cytotoxicity, cytostasis, and induction of cell apoptosis [ 31 ];
- The treatment of hepatic cancer cells appeared to cause cytotoxicity, apoptosis [ 32 ], and an inhibition of proliferation [ 25 , 28 ];
- Other types of cell lines investigated in the included studies were prostate cancer cells, endocervical adenocarcinoma [ 22 ], cervical epidermoid carcinoma cells [ 25 ], testicular cancer cell lines [ 25 ], head and neck cancer [ 25 ], thyroid and pancreatic cancer cells [ 13 ], melanoma, hepatoma, glioblastoma, neuroblastoma [
…”